Suppression of soluble T cell-associated proteins by an anti-interferon-α monoclonal antibody in adult patients with dermatomyositis or polymyositis

類似資料

• A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients
  著者:: Higgs, Brandon W, 等
  出版事項: (2014)
• Soluble interleukin 2 receptors in patients with polymyositis/dermatomyositis.
  著者:: Tokano, Y, 等
  出版事項: (1992)
• Interferon and Biologic Signatures in Dermatomyositis Skin: Specificity and Heterogeneity across Diseases
  著者:: Wong, David, 等
  出版事項: (2012)
• Type I Interferon–Inducible Gene Expression in Blood Is Present and Reflects Disease Activity in Dermatomyositis and Polymyositis
  著者:: Walsh, Ronan J., 等
  出版事項: (2007)
• Nutrition and Polymyositis and Dermatomyositis
  著者:: Loell, Ingela, 等
  出版事項: (2008)